|
|
|
|
|
1
|
Drug Delivery Partnering Agreements in Pharma and Biotech |
Oct 2009 |
$2,395.00 |
|
The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies.
The report provides a
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
2
|
Partnering Agreements in Diagnostics |
Sep 2009 |
$2,395.00 |
|
The Partnering Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
3
|
Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics |
Jul 2009 |
$2,395.00 |
|
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies.
This
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
4
|
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics |
Jun 2009 |
$2,395.00 |
|
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
The report provides a detailed
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
5
|
Practical Guide to Finding Partners in Biopharma |
Apr 2009 |
$995.00 |
|
The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
6
|
Option & Evaluation Agreements in Pharma and Biotech |
Mar 2009 |
$1,995.00 |
|
The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.
This report provides
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
7
|
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition |
Feb 2009 |
$2,395.00 |
|
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies. Fully revised and
more...
Published by: CurrentPartnering
|
|
|
8
|
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd Edition |
Feb 2009 |
$2,395.00 |
|
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market
more...
Published by: CurrentPartnering
|
|
|
9
|
Royalty Financing Agreements in Pharma, Biotech and Diagnostics |
Jan 2009 |
$995.00 |
|
The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.
The report provides a detailed
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
10
|
Product & Asset Purchase Agreements in Pharma, Biotech and Diagnostics |
Nov 2008 |
$2,395.00 |
|
The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.
The focus of the report is on partnerships for business, product, technology and royalty
more...
Published by: CurrentPartnering
|
|
|
11
|
Pre-clinical Stage Partnering Agreements in Biopharma |
Oct 2008 |
$2,395.00 |
|
The Pre-clinical Stage Partnering Agreements in Biopharma report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement.
The report provides a detailed understanding
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
12
|
Discovery Stage Partnering Agreements in Biopharma |
Sep 2008 |
$2,395.00 |
|
The Discovery Stage Partnering Agreements in Biopharma report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement.
The report provides a detailed understanding
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
13
|
Mundipharma Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Mundipharma as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
14
|
Menarini Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Menarini as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
15
|
Daiichi Sankyo Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Daiichi Sankyo as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
16
|
Actavis Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Actavis as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
17
|
Chugai Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Chugai as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
18
|
Partnering with Bigpharma: The Definitive Guide to Partnering Interests, Contacts & Agreements |
Jul 2008 |
$2,995.00 |
|
The Partnering with Bigpharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies.One of the key aspects of partnering is finding those companies
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
19
|
Barr Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Barr Pharmaceuticals as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
20
|
Wyeth Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Wyeth as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
21
|
Watson Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Watson as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
22
|
UCB Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of UCB as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
23
|
Teva Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Teva as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
24
|
Takeda Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Takeda as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
25
|
Solvay Pharma Partnering Guide 2008 |
Jul 2008 |
$395.00 |
|
Using this report, dealmakers will effectively and efficiently determine the suitablility of Solvay as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with
more...
Published by: CurrentPartnering
| Search inside this report |
|
|
|
|
|
0 items
